Antibody Therapeutics is delighted to announce the inaugural Antibody Therapeutics Papers of the Year Award, recognizing exceptional articles published in the previous year. Following polls conducted among thousands of global professionals through professional networks, we are thrilled to honor four outstanding papers published in 2025 as recipients of the Papers of the Year 2025 Award. The awards will be officially presented at the Antibody Therapeutics Symposium, an inaugural conference...

We’re thrilled to announce that ChAbS  LinkedIn page has officially surpassed 20,000 followers ! This milestone reflects the growing global community that shares our mission — to connect industry, academia, and investment and advance innovation in antibody therapeutics. A heartfelt thank you to all our members, partners, and supporters for being part of this journey. Your engagement inspires us to keep building a stronger platform for collaboration and knowledge exchange. Follow us on...

We are excited to announce that the Chinese Antibody Society (CAS) has officially updated its identity. The organization’s new abbreviation is ChAbs, and with it comes a refreshed logo that better reflects our mission and vision. This change marks an important step in strengthening our community presence and advancing antibody research together.